BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10705817)

  • 1. Quantitative analysis of the decay of immunoreactivity in stored prostate needle biopsy sections.
    Vis AN; Kranse R; Nigg AL; van der Kwast TH
    Am J Clin Pathol; 2000 Mar; 113(3):369-73. PubMed ID: 10705817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.
    Vis AN; Noordzij MA; Fitoz K; Wildhagen MF; Schröder FH; van der Kwast TH
    J Urol; 2000 Dec; 164(6):2156-61. PubMed ID: 11061947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of tissue markers p27(kip1), MIB-1, and CD44s for the pre-operative prediction of tumour features in screen-detected prostate cancer.
    Vis AN; van Rhijn BW; Noordzij MA; Schröder FH; van der Kwast TH
    J Pathol; 2002 Jun; 197(2):148-54. PubMed ID: 12015737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.
    Cattoretti G; Becker MH; Key G; Duchrow M; Schlüter C; Galle J; Gerdes J
    J Pathol; 1992 Dec; 168(4):357-63. PubMed ID: 1484317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative prostate needle biopsy p27 correlates with subsequent radical prostatectomy p27, Gleason grade and pathological stage.
    Thomas GV; Schrage MI; Rosenfelt L; Kim JH; Salur G; deKernion JB; Dorey F; Said J; Reiter RE
    J Urol; 2000 Dec; 164(6):1987-91. PubMed ID: 11061897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of cell-cycle associated markers on paraffin embedded and formalin fixed needle biopsies of prostate cancer: correlation of p120 protein expression with AgNOR, PCNA/cyclin, Ki-67/MIB1 proliferation-scores and Gleason gradings.
    Botticelli AR; Casali AM; Botticelli L; Zaffe D
    Eur J Histochem; 1998; 42(1):41-8. PubMed ID: 9615190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic markers in clinically localised prostate cancer.
    Bai XZ; Masters JR; O'Donoghue N; Kirby R; Pan LX; Young M; Stafford M; Parkinson MC
    Int J Oncol; 1999 Apr; 14(4):785-91. PubMed ID: 10087330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p27Kip1 expression is associated with clinical outcome in advanced epithelial ovarian cancer: multivariate analysis.
    Masciullo V; Ferrandina G; Pucci B; Fanfani F; Lovergine S; Palazzo J; Zannoni G; Mancuso S; Scambia G; Giordano A
    Clin Cancer Res; 2000 Dec; 6(12):4816-22. PubMed ID: 11156240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor immunohistochemistry on paraffin-embedded tissue.
    Loda M; Fogt F; French FS; Posner M; Cukor B; Aretz HT; Alsaigh N
    Mod Pathol; 1994 Apr; 7(3):388-91. PubMed ID: 8058713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of microwave oven heating times on androgen receptor antigen retrieval from paraffin-embedded prostatic adenocarcinoma.
    Magi-Galluzzi C; Montironi R; Prete E; Kwan PW; Delellis RA
    Anticancer Res; 1996; 16(5A):2931-6. PubMed ID: 8917409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limiting the diagnosis of atypical small glandular proliferations in needle biopsies of the prostate by the use of immunohistochemistry.
    Helpap B; Köllermann J; Oehler U
    J Pathol; 2001 Mar; 193(3):350-3. PubMed ID: 11241415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-assessment of cytoplasmic and nuclear androgen receptor location in prostate specimens: potential implications for prostate cancer development and prognosis.
    Diallo JS; Aldejmah A; Mouhim AF; Fahmy MA; Koumakpayi IH; Sircar K; Bégin LR; Mes-Masson AM; Saad F
    BJU Int; 2008 May; 101(10):1302-9. PubMed ID: 18294307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreasing of p27(Kip1)and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer.
    Kamai T; Takagi K; Asami H; Ito Y; Oshima H; Yoshida KI
    Br J Cancer; 2001 May; 84(9):1242-51. PubMed ID: 11336477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications.
    Davidson B; Risberg B; Berner A; Nesland JM; Tropé CG; Kristensen GB; Bryne M; Goscinski M; van de Putte G; Flørenes VA
    Gynecol Oncol; 2001 Nov; 83(2):249-56. PubMed ID: 11606079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p27kip1 expression distinguishes papillary hyperplasia in Graves' disease from papillary thyroid carcinoma.
    Erickson LA; Yousef OM; Jin L; Lohse CM; Pankratz VS; Lloyd RV
    Mod Pathol; 2000 Sep; 13(9):1014-9. PubMed ID: 11007042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of neuroendocrine staining and androgen receptor expression in incidental prostatic adenocarcinoma: prognostic implications.
    Theodoropoulos VE; Tsigka A; Mihalopoulou A; Tsoukala V; Lazaris AC; Patsouris E; Ghikonti I
    Urology; 2005 Oct; 66(4):897-902. PubMed ID: 16230178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
    Hommura F; Dosaka-Akita H; Mishina T; Nishi M; Kojima T; Hiroumi H; Ogura S; Shimizu M; Katoh H; Kawakami Y
    Clin Cancer Res; 2000 Oct; 6(10):4073-81. PubMed ID: 11051259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
    Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
    Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term biologic response to withdrawal of hormone replacement therapy in patients with invasive breast carcinoma.
    Prasad R; Boland GP; Cramer A; Anderson E; Knox WF; Bundred NJ
    Cancer; 2003 Dec; 98(12):2539-46. PubMed ID: 14669271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.